Share-based Compensation (Tables)

12 Months Ended

Jun. 30, 2019

Share-based Compensation

Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

	June 30,			June 30,			June 30,
	2019			2018			2017
Risk-free interest rate		2.9	%		2.1	%		1.1	%
Expected volatility		58.4	%		57.6	%		55.6	%
Expected dividend yield		—			—			—
Forfeiture rate		6.5	%		6.5	%		6.5	%
Expected term		5.3	years		5.4	years		5.2	years
Weighted average fair value	$	6.52		$	11.25		$	15.33

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2016	1,730	$	16.77	$	19,524	6.3
Granted	11		31.30
Exercised	(234)		7.38	$	4,849
Forfeited, expired or repurchased	(32)		33.04
Outstanding at June 30, 2017	1,475	$	18.02	$	12,212	5.7
Granted	50		21.43
Exercised	(445)		7.23	$	4,243
Forfeited, expired or repurchased	(23)		30.83
Outstanding at June 30, 2018	1,057	$	22.46	$	2,584	5.4
Granted	73		12.20
Exercised	(94)		4.06	$	311
Forfeited, expired or repurchased	(464)		30.61
Outstanding at June 30, 2019	572	$	17.56	$	273	5.0
Vested and expected to vest at June 30, 2019	566	$	17.59	$	273	5.0
Exercisable at June 30, 2019	469	$	18.09	$	273	4.2

Summary of non-vested restricted stock awards

		Weighted
		Average Grant -		Aggregate
(In thousands)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2016	167	$	48.22
Granted	298		24.73
Vested	(86)		42.60	$	2,564
Forfeited	(45)		32.90
Non-vested at June 30, 2017	334	$	30.71
Granted	641		18.01
Vested	(191)		31.30	$	4,104
Forfeited	(80)		20.95
Non-vested at June 30, 2018	704	$	20.06
Granted	1,176		9.90
Vested	(434)		19.75	$	4,107
Forfeited	(158)		14.00
Non-vested at June 30, 2019	1,288	$	11.63

Schedule of non-vested performance-based shares

		Weighted
		Average Grant -		Aggregate
(In thousands, except for weighted average price and life data)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2017	—		—
Granted	47		25.58
Vested	(27)		25.58	$	574
Forfeited	—		—
Non-vested at June 30, 2018	20	$	25.58
Granted	52	$	17.69
Vested	—	$	—	$	—
Forfeited	—	$	—
Non-vested at June 30, 2019	72	$	19.92

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

	For Fiscal Year Ended June 30,
(In thousands)	2019		2018		2017
Selling, general and administrative expenses	$	5,715	$	7,570	$	5,855
Research and development expenses		750		680		661
Cost of sales		2,562		1,646		1,203
Total	$	9,027	$	9,896	$	7,719
Tax benefit at statutory rate	$	2,031	$	2,919	$	2,818